Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment—the QUALIPROST study

Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data

(2015) Giacomo Novara et al.   BJU INTERNATIONAL

Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study

(2015) Luca Cindolo et al.   EUROPEAN UROLOGY

Comparison of Tamsulosin Plus Serenoa Repens with Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Korean Men: 1-Year Randomized Open Label Study

(2015) Young Woo Ryu et al.   UROLOGIA INTERNATIONALIS

Impact of Medical Treatments for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia on Ejaculatory Function: A Systematic Review and Meta‐Analysis

(2014) Mauro Gacci et al.   Journal of Sexual Medicine

Validación de la versión española del Cuestionario Benign Prostatic Hyperplasia Impact Index. “Estudio Validart”

(2013) J. Carballido Rodríguez et al.   Actas Urologicas Espanolas

Management of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia in Real-life Practice in France: A Comprehensive Population Study

(2013) Bertrand Lukacs et al.   EUROPEAN UROLOGY

Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells

(2013) Nanor Sirab et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia: temporal trends of prescription and hospitalization rates over 5 years in a large population of Italian men

(2013) Luca Cindolo et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Dutasteride on Benign Prostatic Hyperplasia: A Meta-analysis on Randomized Clinical Trials in 6460 Patients

(2013) Xiao-Jun Wu et al.   UROLOGY

Hexanic lipidosterolic extract ofSerenoa repensinhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1,in vitro

(2012) Alain Latil et al.   BJU INTERNATIONAL

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review

(2012) Roderick MacDonald et al.   BJU INTERNATIONAL

Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial

(2011) Hartmut Porst et al.   EUROPEAN UROLOGY

Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms

(2011) Michael J. Barry   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia

(2011) Richard-Olivier Fourcade et al.   WORLD JOURNAL OF UROLOGY

Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial

(2009) Jack Barkin et al.   BJU INTERNATIONAL

The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study

(2009) Claus G. Roehrborn et al.   EUROPEAN UROLOGY

Medical treatments for benign prostatic hyperplasia and sexual function

(2008) François Giuliano   BJU INTERNATIONAL

Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials

(2008) Mark Emberton et al.   BJU INTERNATIONAL

Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice

(2008) Guy Vallancien et al.   BJU INTERNATIONAL

Comparison of the Potency of Different Brands of Serenoa Repens Extract on 5α-Reductase Types I and II in Prostatic Co-Cultured Epithelial and Fibroblast Cells

(2008) Francesco Scaglione et al.   PHARMACOLOGY